Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important?

Area of Science:

• Cardiology
• Transplantation Immunology
• Medical Research

Background:

• Cardiac allograft vasculopathy (CAV) is a significant long-term complication following heart transplantation (HT).
• Identifying pre-transplant and donor-related risk factors is crucial for predicting CAV development.
• Recipient profile and medical history of the donor play a role in CAV pathogenesis.

Purpose of the Study:

• To determine the primary risk factors associated with the development of cardiac allograft vasculopathy (CAV).
• To investigate both pre-transplant recipient factors and donor-related medical history influencing CAV.
• To analyze non-immunologic, immunologic, and donor-specific risk factors for CAV post-HT.

Main Methods:

• A cohort of 147 heart transplantation (HT) patients underwent post-transplant coronary angiography.
• Risk factors analyzed included recipient non-immunologic (lipids, hypertension, diabetes) and immunologic (rejection episodes, CMV) factors, and donor characteristics (age, sex).
• Univariate and multivariate Cox regression models were employed to identify significant predictors of CAV.

Main Results:

• Cardiac allograft vasculopathy (CAV) was identified in 48 patients.
• Univariate analysis showed baseline high-density lipid (HDL), acute cellular rejection (ACR), acute humoral rejection (AMR), cytomegalovirus (CMV), and donor age were significant risk factors.
• Multivariate analysis confirmed baseline HDL, ACR episodes, donor age, and CMV infection as independent predictors of CAV frequency.

Conclusions:

• Older donor age is strongly associated with an increased risk of developing cardiac allograft vasculopathy (CAV).
• A combination of older donor age, low recipient HDL levels, and immunologic factors (ACR, CMV infection) significantly contributes to CAV development after HT.